Joseph Ojonugwa Shaibu

Mr. Joseph Ojonugwa Shaibu


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
11 January 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
JSJoseph Ojonugwa Shaibu
Joseph Ojonugwa Shaibu
COChika Kingsley Onwuamah
Chika Kingsley Onwuamah
AJAyorinde Babatunde James
Ayorinde Babatunde James
AOAzuka Patrick Okwuraiwe
Azuka Patrick Okwuraiwe
OAOlufemi Samuel Amoo
Olufemi Samuel Amoo
RARosemary Ajuma Audu
Rosemary Ajuma Audu
In an outbreak, effective detection of the aetiological agent(s) involved using molecular techniques is key to efficient diagnosis, early prevention and management of the spread. However, sequencing is necessary for mutation monitoring and tracking of clusters of transmission, development of diagnostics and for vaccines and drug development. Many sequencing methods are fast evolving to reduce test turn-around-time and to increase through-put compared to Sanger sequencing method; however, Sanger sequencing remains the gold standard for clinical research sequencing with its 99.99% accuracy This study sought to generate sequence data of SARS-CoV-2 using Sanger sequencing method and to characterize them for possible site(s) of mutations. About 30 pairs of primers were designed, synthesized, and optimized using endpoint PCR to generate amplicons for the full length of the virus. Cycle sequencing using BigDye Terminator v.3.1 and capillary gel electrophoresis on ABI 3130xl genetic analyser were performed according to the manufacturers’ instructions. The sequence data generated were assembled and analysed for variations using DNASTAR Lasergene 17 SeqMan Ultra. Total length of 29,760bp of SARS-CoV-2 was assembled from the sample analysed and deposited in GenBank with accession number: MT576584. Blast result of the sequence assembly shows a 99.97% identity with the reference sequence. Variations were noticed at positions: nt201, nt2997, nt14368, nt16535, nt20334, and nt28841-28843, which caused amino acid alterations at the S (aa614) and N (aa203-204) regions. The mutations observed at S and N-gene in this study may be indicative of a gradual changes in the genetic coding of the virus hence, the need for active surveillance of the viral genome.

15 October 2022 in BMC Public Health
Verified
Journal Article
Open access
PDF file
NFNing Feng
Ning Feng
OEOliver Chukwujekwu Ezechi
Oliver Chukwujekwu Ezechi
MUMabel Uwandu
Mabel Uwandu
BABowofoluwa Sharon Abimbola
Bowofoluwa Sharon Abimbola
GVGrace Deborah Vincent
Grace Deborah Vincent
PTPopgec Team
Popgec Team
To evaluate the feasibility and performance of self-collected vaginal swab samples for HPV screening among women in Lagos, Nigeria. A cross-sectional study was implemented from March to August 2020 among sexually active women. Study participants provided same-day paired vaginal swab samples. Medic-sampling and poster-directed self-sampling methods were used to collect the two samples per participant. A real-time PCR assay detected HPV 16, HPV 18, other-high-risk (OHR) HPV, and the human β-globin gene. The self-collected samples’ sensitivity, specificity, and accuracy were determined against the medic-collected samples using the MedCalc Online Diagnostic Calculator. Of the 213 women aged 16 ~ 63-year-old recruited, 187 (88%) participants had concordant results, while 26 (12%) participants had discordant results. Among the 187 concordant results, 35 (19%) were HPV positive, 150 (80%) participants were HPV negative, and two (1%) were invalid. 18 (69%) out of the 26 discordant samples were invalid. The self-collected sample was invalid for 14 (54%) participants. Two (8%) medic-collected samples were invalid. Compared to the medic-collected sample, the self-collected sample was 89.80% (95% CI: 77.77 ~ 96.60%) sensitive and 98.21% (95% CI: 94.87 ~ 99.63%) specific, with an accuracy of 96.31% (95% CI: 92.87 ~ 98.40%). The mean age for HPV positive and negative participants were 39 and 40, respectively, with an ANOVA p-value of 0.3932. The stratification of HPV infection by the age group was not statistically significant (P > 0.05). With high accuracy of 96%, self-collected sampling is adequate when tested with real-time PCR and may increase the uptake of HPV testing. Though more self-collected samples were invalid than medic-collected samples, most likely due to poor collection, they could be identified for repeat testing. Future implementation can avoid this error with improved guidance and awareness.

18 August 2023 in BMC Infectious Diseases
Verified
Journal Article
Open access
PDF file
JSJoseph Ojonugwa Shaibu
Joseph Ojonugwa Shaibu
KAKabiru Olusegun Akinyemi
Kabiru Olusegun Akinyemi
OUOshilonyah Henry Uzor
Oshilonyah Henry Uzor
RARosemary Ajuma Audu
Rosemary Ajuma Audu
AOAkeeb Bola Oriowo Oyefolu
Akeeb Bola Oriowo Oyefolu
Arboviral infections are fast becoming a global public health concern as a result of its high fatality rate and sporadic spread. From the outbreak of Zika virus in the Americas, the endemicity of Yellow fever in West Africa and South America, outbreaks of West Nile virus in South Africa to the year-round and national risk of Dengue fever in Mainland China and India. The war against emerging and re-emerging viral infection could probably lead to the next pandemic. To be above the pending possible arboviral pandemic, consistent surveillance of these pathogens is necessary in every society. This study was aimed at conducting a surveillance for Yellow fever virus, Zika virus, Chikungunya virus, Dengue virus and Rift Valley fever virus in four states in Nigeria using molecular techniques. A cross-sectional study involving 1600 blood samples collected from febrile patients in Lagos, Kwara, Ondo and Delta States between 2018 and 2021 was conducted using Real time polymerase chain reaction for detection of the pathogens. Extraction and purification of viral RNA were done using Qiagen Viral RNA Mini Kit. Samples were analyzed using One Step PrimeScript III RT-PCR mix (Takara Bio) alongside optimized primers and probes designed in-house. Positive samples were sequenced on MinION platform (Nanopore technologies). Bioinformatic and phylogenetic analysis were performed with DNASTAR Lasergene 17.3. All the RNA extracted from samples collected from the four states were negative for ZIKV RNA, RVFV RNA, CHIKV RNA and DENV RNA. However, twelve of the samples (2%) tested positive for YFV RNA. Three full genomes of sizes 10,751 bp, 10,500 bp and 10,715 bp were generated and deposited in GenBank with accession numbers: ON323052, ON323053 and ON323054 respectively. Phylogenetic analysis shows clustering within lineage 3 of West African genotype. This result shows an active spread of Yellow fever in Delta State, Nigeria. However, there is no emergence of a new genotype There is a need for an intense surveillance of Yellow fever virus in Nigeria to avert a major outbreak.

1 May 2021 in Immunobiology
Verified
Journal Article
Closed access
JSJoseph Ojonugwa Shaibu
Joseph Ojonugwa Shaibu
OSOlumuyiwa Babalola Salu
Olumuyiwa Babalola Salu
OAOlufemi Samuel Amoo
Olufemi Samuel Amoo
IIIfeoma Idigbe
Ifeoma Idigbe
AMAdesola Zaidat Musa
Adesola Zaidat Musa
RARosemary Ajuma Audu
Rosemary Ajuma Audu

31 October 2022 in medRxiv
Verified
Preprint
Open access
PDF file
JSJoseph Ojonugwa Shaibu
Joseph Ojonugwa Shaibu
ODOlufemi B. Daodu
Olufemi B. Daodu
KAKabiru Olusegun Akinyemi
Kabiru Olusegun Akinyemi
RARosemary Ajuma Audu
Rosemary Ajuma Audu
AOAkeeb O. Bola Oyefolu
Akeeb O. Bola Oyefolu
In Sub-Saharan Africa, CCHFV has been reported in some of the countries with resultant seroprevalences ranging from 1.65-44%, 0.37-75%, 19-74% amongst humans, ticks and cattle respectively using ELISA technique. Strains classified as Africa clade 1,2 and 3 have been established to be circulating in Sub-Saharan Africa from few molecular studies carried out. CCHFV has part of its nomenclature rooted in Africa, however, the actual spread of the virus across sub-Saharan Africa is poorly known. This paucity of knowledge is attributed to less work done in the quest to understand this virus better. Most researches, which were quite limited, carried out across Africa were on antibody detection using ELISA methods with little information on molecular characterization. The aim of this review is to harmonize the studies carried out in Sub-Saharan Africa on CCHFV between 1969 -2022 with respect to seroprevalence, viral identification and isolation, molecular characterization and genomic analysis. Articles are retrieved from public databases such as google search, PubMed, Google scholar and ResearchGate, filtered using PRISMA concept and data extracted from eligible articles and analyzed. In this study the overall average seroprevalence of CCHFV in Humans, Ticks, Cattle, sheep and Goats are 13.6%, 18.1%, 44.3%, 11.3%, 16.3% respectively. South Africa has the highest seroprevalence (20.8%) among humans and Uganda (2.5%) has the lowest. The prevalence of CCHFV in many African countries is still yet unknown though there is clear evidence of exposure of people within the region to CCHFV. Limitations in sensitivity and specificity of diagnostic techniques such as agar gel precipitation test, haemagglutination test and complement fixation test used at some instance suggest a need for more reliable techniques. Author’s summary Crimea-Congo haemorrhagic fever virus is carried by ticks. It has a high fatality rate among humans. It is implicated in haemorrhagic fever with bleeding through the nose and mouth. CCHFV is fast spreading across the world but little is known it in Sub-Saharan Africa. Many individuals in this region are herders, they are daily exposed to ticks; they regularly come down with febrile illnesses that are most times misdiagnosed as either malaria or typhoid. In the course of treating for malaria or typhoid, some die. There is no awareness ongoing in the communities about this infection and its danger to the population, preventive measures with respect to personal hygiene, cleanliness of the abattoirs and general environments and the need to seek medical attention and avoid self-medication. In this review it is shown that there is evidence of spread of CCHFV in Sub-Saharan Africa, however, there is paucity of information. This lack is as result of many factors such as lack of funds for research, porous security that makes it difficult tracing, lack of effective diagnosis of viral pathogens and so on.

1 January 2021 in PAMJ - One Health
Verified
Journal Article
Open access
AJAyorinde James
Ayorinde James
OSOlumuyiwa Babalola Salu
Olumuyiwa Babalola Salu
JSJoseph Ojonugwa Shaibu
Joseph Ojonugwa Shaibu
COChika Kingsley Onwuamah
Chika Kingsley Onwuamah
BMBamidele Paul Mutiu
Bamidele Paul Mutiu
SOSunday Aremu OMILABU
Sunday Aremu OMILABU
INTRODUCTION: Heightened surveillance of the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) 2019 outbreak in Wuhan, China activated several collaborative laboratory drills on its detection by health institutions in Nigeria. We hereby detail the laboratory detection and confirmation of the novel SARS-CoV-2 virus of the index case imported into Nigeria. METHODS: viral RNA from sputum sample of the index case was tested for SARS-CoV-2 envelope (E) and RNA dependent RNA polymerase (RdRp) genes using quantitative reverse transcription-polymerase chain reaction (qRT-PCR). Genetic analysis using a partial sequence of RdRp gene was used for laboratory confirmation, evolutionary inferences, and relatedness to previous strains of betacoronaviruses in Nigeria. RESULTS: both qRT-PCR for the E and RdRp genes indicated the presence of the SARS-CoV-2 RNA by showing cycle threshold (ct) values of 20.27 and 25.26 respectively. On successful completion of the sequencing run, data aligned with >98% similarity of the 2019 circulating strain of Coronavirus SARS-CoV-2. Evolutionary algorithms revealed that the sequence (RdRp gene) of the outbreak circulating strains were more conserved unlike previous coronavirus outbreaks. Data showed that some coronaviruses belonging to the BetaCoV genus had earlier been reported in bats and camels in Nigeria indicating the possibility of sero-protection in exposed populations. CONCLUSIONS: pre-laboratory drills prompted early diagnosis and confirmation of SARS-CoV-2 index case in Nigeria initiating rapid case-definition, contact tracing, and successful epidemiological management of the outbreak. Rapid sequencing of the viral genome during strategic points of the outbreak curve and making libraries of new variants for improved vaccine development are recommended.